Breast Cancer Res Treat (2017) 165:469–470 DOI 10.1007/s10549-017-4352-z REBUTTAL LETTER Gail Lewis Phillips Received: 27 May 2017 / Accepted: 19 June 2017 / Published online: 30 June 2017 Springer Science+Business Media, LLC 2017 Dear Breast Cancer Research and Treatment Editors: brain microenvironment as a resistance mechanism to PI3K inhibitors in experimental brain lesions. Interestingly, it On behalf of my co-authors, we would like to thank Drs. was also demonstrated that Neuregulins, a family of HER3 Askoxylakis, Kodack, Ferraro, and Jain for their com- ligands, could desensitize tumor cells to PI3K inhibition, mentary on our recently published paper ‘‘Trastuzumab and this was reversed by co-treatment with a HER3 anti- Uptake and its Relation to Efﬁcacy in an Animal Model of body or with pertuzumab, a HER2-HER3 dimerization HER2-Positive Breast Cancer Brain Metastasis (Breast inhibitor. The ﬁndings in this manuscript provide addi- Cancer Res Treat DOI: 10.1007/s10549-017-4279-4)’’. tional support for our hypothesis of differences in Brieﬂy, our ﬁndings demonstrated uptake of labeled tras- microenvironment inﬂuencing response to targeted ther- tuzumab in intracranial brain grafts that was equivalent to apy, and conﬁrm, in different mouse tumor models, our uptake in orthotopic (mammary fat pad, MFP) tumors, yet data showing enhanced efﬁcacy with
Breast Cancer Research and Treatment – Springer Journals
Published: Jun 30, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera